As a Shareholder in Maynard’s Intellectual Property Practice, Matt advises emerging and established biotechnology, agtech, medical device, SaaS, diagnostic, and life science companies regarding legal and business issues associated with the development and commercialization of their products, services and technologies. Matt’s scientific background in microbiology and biomedical sciences allows him to work closely with his clients in establishing a strategic direction and structures and negotiates mission-critical business arrangements designed to maximize the value of their businesses.
Matt regularly assists clients in complex partnering and licensing arrangements, merger and acquisition transactions, research and development services agreements, and manufacture, supply, and distribution agreements. Matt also represents clients in their dealings with academic institutions and other not-for-profit organizations.
As a complement to his transactional IP practice, Matt is registered to practice in the United States Patent and Trademark Office and assists his clients with patent and trademark protection.
Matt received his Ph.D. in Biomedical Sciences at the University of Florida, where he gained research experience in molecular biology, biochemistry, and translational medicine.